Cargando…

Tristetraprolin inhibits gastric cancer progression through suppression of IL-33

Tristetraprolin (TTP) is an adenine/uridine (AU)-rich element (ARE)-binding protein that can induce degradation of mRNAs. In this study, we report that TTP suppresses the expression of interleukin-33 (IL-33), a tumor-promoting inflammatory cytokine, and thereby inhibits the progression of gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Kaiyuan, Wang, Hao, Shan, Ting, Chen, Yigang, Zhou, Hong, Zhao, Qin, Xia, Jiazeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830935/ https://www.ncbi.nlm.nih.gov/pubmed/27074834 http://dx.doi.org/10.1038/srep24505

Ejemplares similares

Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity
por: Guo, Jian, et al.
Publicado: (2018)

Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1
por: Wang, Hao, et al.
Publicado: (2018)

Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer
por: Shan, Ting, et al.
Publicado: (2017)

Tristetraprolin Prevents Gastric Metaplasia in Mice by Suppressing Pathogenic Inflammation
por: Busada, Jonathan T., et al.
Publicado: (2021)

Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells
por: Vo, Mai-Tram, et al.
Publicado: (2017)

Tristetraprolin: A novel target of diallyl disulfide that inhibits the progression of breast cancer
por: Xiong, Ting, et al.
Publicado: (2018)

Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses
por: Wang, Qinghong, et al.
Publicado: (2017)

Roles of Tristetraprolin in Tumorigenesis
por: Park, Jeong-Min, et al.
Publicado: (2018)

To promote or inhibit glioma progression, that is the question for IL-33
por: Robbins, Stephen M., et al.
Publicado: (2020)

Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells
por: Yoon, Nal Ae, et al.
Publicado: (2016)

IL-4–Stat6 Signaling Induces Tristetraprolin Expression and Inhibits TNF-α Production in Mast Cells
por: Suzuki, Kotaro, et al.
Publicado: (2003)

Linalyl Acetate Ameliorates Mechanical Hyperalgesia Through Suppressing Inflammation by TSLP/IL-33 Signaling
por: Lu, Ying-Yi, et al.
Publicado: (2022)

Role of Tristetraprolin in the Resolution of Inflammation
por: Rappl, Peter, et al.
Publicado: (2021)

Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin
por: Ryu, Jinhyun, et al.
Publicado: (2015)

Deficiency of Tristetraprolin Triggers Hyperthermia through Enhancing Hypothalamic Inflammation
por: Jeong, Da Yeon, et al.
Publicado: (2021)

The Tristetraprolin Family of RNA-Binding Proteins in Cancer: Progress and Future Prospects
por: Saini, Yogesh, et al.
Publicado: (2020)

IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
por: Wang, Kailing, et al.
Publicado: (2017)

Regulation and localization of endogenous human tristetraprolin
por: Fairhurst, Anna-Marie, et al.
Publicado: (2003)

Tristetraprolin is a novel regulator of BDNF
por: Kumar, Anmol, et al.
Publicado: (2014)

Tristetraprolin regulation of interleukin-22 production
por: Härdle, Lorena, et al.
Publicado: (2015)

Thymoquinone-Induced Tristetraprolin Inhibits Tumor Growth and Metastasis through Destabilization of MUC4 mRNA
por: Lee, Se-Ra, et al.
Publicado: (2019)

Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy
por: Dolicka, Dobrochna, et al.
Publicado: (2020)

Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin
por: Ross, Ewan A., et al.
Publicado: (2015)

Tumor suppressing effects of tristetraprolin and its small double‐stranded RNAs in bladder cancer
por: Jiang, Wen, et al.
Publicado: (2020)

The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin
por: Wu, Xunwei, et al.
Publicado: (2018)

IL-33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway
por: Huang, Ning, et al.
Publicado: (2021)

Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer
por: Lee, Won Hyeok, et al.
Publicado: (2022)

Erratum: Tristetraprolin regulation of interleukin-22 production
por: Härdle, Lorena, et al.
Publicado: (2015)

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors
por: Lee, Won Hyeok, et al.
Publicado: (2020)

IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
por: Eissmann, Moritz F., et al.
Publicado: (2019)

Targeting Tristetraprolin Expression or Functional Activity Regulates Inflammatory Response Induced by MSU Crystals
por: lv, Linxi, et al.
Publicado: (2021)

Tristetraprolin targets Nos2 expression in the colonic epithelium
por: Eshelman, Melanie A., et al.
Publicado: (2019)

Tristetraprolin expression by keratinocytes protects against skin carcinogenesis
por: Assabban, Assiya, et al.
Publicado: (2021)

IL-33 notably inhibits the growth of colon cancer cells
por: Chen, Xuhui, et al.
Publicado: (2018)

Trifuhalol A Suppresses Allergic Inflammation through Dual Inhibition of TAK1 and MK2 Mediated by IgE and IL-33
por: Bong, Sim-Kyu, et al.
Publicado: (2022)

IL-1β Suppresses Innate IL-25 and IL-33 Production and Maintains Helminth Chronicity
por: Zaiss, Mario M., et al.
Publicado: (2013)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer
por: Zhang, Mingdi, et al.
Publicado: (2016)

FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2023)

Tristetraprolin: a weapon against HPV-induced cervical cancer?
por: Gallouzi, Imed-Eddine, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dibsr5ial2q9j99mq5grugsht3